Search results
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
Motley Fool via Yahoo Finance· 6 months agoPfizer (NYSE: PFE) was a top performer when the U.S. government was shoveling COVID-related revenue...
2 Dividend Stocks That Could Double Your Return in 10 Years
Motley Fool· 1 year agoPfizer (NYSE: PFE) and AbbVie (NYSE: ABBV) have produced strong total returns over the past decade,...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
Motley Fool via Yahoo Finance· 3 weeks agoYour long-term investment portfolio should have meaningful exposure to healthcare stocks. People...
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
InvestorPlace via Yahoo Finance· 1 month agoIn the changing environment of 2024, astute investors have a plethora of options to strengthen their...
Pfizer's India unit posts 3% rise in Q4 profit
Reuters via Yahoo News· 1 year agoBENGALURU (Reuters) - Pfizer Ltd, the Indian unit of U.S. pharmaceutical group Pfizer Inc, on Monday reported a 3.1% rise in fourth-quarter profit,...
The Bull Market Left These 3 Stocks Behind, but They're Buys Right Now
Motley Fool via Yahoo Finance· 4 months agoWith the stock market recently hitting new all-time highs again, times are exciting for people who...
Here's Why Pfizer Stock Is Looking Increasingly Attractive
Motley Fool· 1 year agoYou might already know the conventional wisdom about Pfizer (NYSE: PFE). The company depends heavily...
Want to Collect a High Dividend Every Month? Buy These 3 Stocks
Motley Fool· 2 years agoDividend stocks are a good way to supplement your income. Three stocks that provide high yields that...
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
Motley Fool· 9 months agoIf you have a decent nest egg saved up, you can use it to invest in dividend stocks to improve your...
Can Pfizer Beat GSK and Moderna in This $10 Billion Market?
Motley Fool· 1 year agoPfizer (NYSE: PFE) and GSK (NYSE: GSK) have competed against each other for years. Moderna (NASDAQ:...